These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21995152)

  • 1. Thrombin activatable fibrinolysis inhibitor (TAFI) is not associated with recurrent miscarriage.
    Sezer SD; Baz A; Küçük M; Odabaşi AR; Serter M; Yüksel H
    Clin Exp Obstet Gynecol; 2011; 38(3):228-31. PubMed ID: 21995152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is thrombin-activatable fibrinolysis inhibitor antigen (TAFIag) level significant in recurrent miscarriage?
    Kayatas S; Kumru P; Sariibrahim B; Cakar E; Sahin T; Kartal C
    Clin Exp Obstet Gynecol; 2014; 41(4):448-50. PubMed ID: 25134296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of early recurrent fetal loss and levels of thrombin-activatable fibrinolysis inhibitor.
    Legnani C; Bovara M; Valdrè L; Cosmi B; Caniato A; Palareti G
    Thromb Res; 2012 Aug; 130(2):237-41. PubMed ID: 22032800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients.
    Eser A; Inegol Gumus I; Erdamar H; Kaygusuz I; Yildirim M; Usluogullari B; Duran Erdolu M; Simavli SA; Yigitoglu R; Ozturk Turhan N
    Taiwan J Obstet Gynecol; 2016 Feb; 55(1):60-3. PubMed ID: 26927250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in acromegaly patients in remission.
    Erdoğan M; Özbek M; Akbal E; Üreten K
    Turk J Med Sci; 2019 Oct; 49(5):1381-1385. PubMed ID: 31549496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin activatable fibrinolysis inhibitor and clot lysis time in women with recurrent miscarriage associated with the antiphospholipid syndrome.
    Martínez-Zamora MA; Creus M; Tassies D; Bové A; Reverter JC; Carmona F; Balasch J
    Fertil Steril; 2010 Nov; 94(6):2437-40. PubMed ID: 20378110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of levothyroxine suppression therapy on plasma thrombin activatable fibrinolysis inhibitor antigen levels in benign thyroid nodules.
    Akinci B; Demir T; Comlekci A; Yener S; Ozcan MA; Karaoglu O; Yuksel F; Secil M; Yesil S
    Med Princ Pract; 2011; 20(1):23-8. PubMed ID: 21160209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin-Activatable Fibrinolysis Inhibitor Gene Polymorphism (TAFI1040C/T) in Women With Recurrent Spontaneous Abortion.
    ElDanasori N; Abulata N; Shaheen IA; ElGendy AM; El-Khayat W
    Clin Appl Thromb Hemost; 2018 Apr; 24(3):532-535. PubMed ID: 28301909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does an enzyme other than thrombin contribute to unexpected changes in the levels of the different forms of thrombin activatable fibrinolysis inhibitor in patients with hemophilia A, hemophilia B and von Willebrand disease?
    Antovic JP; Schulman S; An SS; Greenfield RS; Blombäck M
    Scand J Clin Lab Invest; 2004; 64(8):745-51. PubMed ID: 15719893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation.
    Watanabe R; Wada H; Watanabe Y; Sakakura M; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Nobori T; Shiku H
    Thromb Res; 2001 Oct; 104(1):1-6. PubMed ID: 11583733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels in overt and subclinical hypothyroid patients were reduced by levothyroxine replacement.
    Akinci B; Comlekci A; Ali Ozcan M; Demir T; Yener S; Demirkan F; Yuksel F; Yesil S
    Endocr J; 2007 Feb; 54(1):45-52. PubMed ID: 17090955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does thrombin activatable fibrinolysis inhibitor (TAFI) contribute to impairment of fibrinolysis in patients with preeclampsia and/or intrauterine fetal growth retardation?
    Antovic JP; Rafik Hamad R; Antovic A; Blombäck M; Bremme K
    Thromb Haemost; 2002 Oct; 88(4):644-7. PubMed ID: 12362237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship Between Polymorphism of Thrombin-Activatable Fibrinolysis Inhibitor Gene +1040C/T and a Cohort of Chinese Women With Recurrent Spontaneous Abortion.
    Fang P; Cai D; Du L; Shen F; Zhang C; Li M
    Clin Appl Thromb Hemost; 2021; 27():10760296211029720. PubMed ID: 34189940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe.
    Juhan-Vague I; Morange PE; Aubert H; Henry M; Aillaud MF; Alessi MC; Samnegård A; Hawe E; Yudkin J; Margaglione M; Di Minno G; Hamsten A; Humphries SE;
    Arterioscler Thromb Vasc Biol; 2002 May; 22(5):867-73. PubMed ID: 12006404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of combined vascular endothelial growth factor, endothelial nitric oxide synthase and thrombin-activatable fibrinolysis inhibitor genetic polymorphisms among Egyptian patients with recurrent spontaneous abortion.
    Abulata NN; Shaheen IA; Osman OM; Hussein AM; El-Khayat WM
    J Obstet Gynaecol Res; 2019 Jun; 45(6):1106-1113. PubMed ID: 30968528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and activity assay in patients with primary hypothyroidism.
    Ermantas N; Guldiken S; Demir M; Tugrul A
    Clin Appl Thromb Hemost; 2010 Oct; 16(5):568-73. PubMed ID: 19959491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in diabetic foot ulcers.
    Erdogan M; Solmaz S; Canataroglu A; Kulaksızoglu M; Cetinkalp S; Ozgen AG; Saygili F; Yilmaz C
    Endocrine; 2010 Jun; 37(3):449-54. PubMed ID: 20960167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between TAFI antigen and Ala147Thr polymorphism of the TAFI gene and the angina pectoris incidence. The PRIME Study (Prospective Epidemiological Study of MI).
    Morange PE; Juhan-Vague I; Scarabin PY; Alessi MC; Luc G; Arveiler D; Ferrieres J; Amouyel P; Evans A; Ducimetiere P;
    Thromb Haemost; 2003 Mar; 89(3):554-60. PubMed ID: 12624641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia.
    Meijers JC; Oudijk EJ; Mosnier LO; Bos R; Bouma BN; Nieuwenhuis HK; Fijnheer R
    Br J Haematol; 2000 Mar; 108(3):518-23. PubMed ID: 10759708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.
    Antovic JP; Blombäck M
    Thromb Res; 2002 Apr; 106(1):59-62. PubMed ID: 12165290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.